Influence of behavioral therapies on awake bruxism, biopsychosocial factors and orofacial pai
Phase 4
- Conditions
- Bruxism
- Registration Number
- RBR-10gz4s59
- Lead Sponsor
- Mariana Barbosa Câmara de Souza
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Not specified
- Target Recruitment
- Not specified
Inclusion Criteria
Adults with at least 24 teeth; diagnosed with awake bruxism; body mass index (BMI) between 18.5 and 24.9 kg, considered normal; and good general health.
Exclusion Criteria
Individuals under medical, psychological or pharmacological treatment; individuals that have received any therapy for awake or sleep bruxism in the past 12 months; patients with any type of prosthesis, orthodontic appliances, and those with neuropathic pain, primary headache or neuralgias.
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method It is expected to find, by using surface electromyography, a reduction of at least 10% of the masseter muscles activity in the pre and post-intervention measurements
- Secondary Outcome Measures
Name Time Method It is expected to find, with the pressure pain threshold test by using a digital algometer, a reduction of at least 30% sensitivity of the masseter and temporal muscles, in the pre and post-intervention measurements;It is expected to find, by means of the Perceived Stress Scale questionnaire, a reduction of at least 20% in stress levels, in the pre and post-intervention measurements;It is expected to find, by means of the Hospital Anxiety and Depression Scale questionnaire, a reduction of at least 20% in anxiety levels, in the pre and post-intervention measurements.;It is expected to find, by means of the Hospital Anxiety and Depression Scale questionnaire, a reduction of at least 20% in depression levels, in the pre and post-intervention measurements.;It is expected to find, by means of the WHOQOL-bref questionnaire, an improvement of at least 10% in quality of life scores, in the pre and post-intervention measurements